Document Detail


Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
MedLine Citation:
PMID:  20203107     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Nicotine immunization is under consideration as an intervention for smoking cessation. Therefore, it was of interest to evaluate the effects of nicotine antibodies on the withdrawal syndrome following termination of chronic nicotine administration. METHODS: Experiment 1 determined whether passive immunization following continuous nicotine infusion would alter the intensity of nicotine withdrawal syndrome in the rat. Fourteen rats were rendered nicotine dependent by 7 days of subcutaneous nicotine bitartrate infusion. On the final day, seven rats received 150 mg intraperitoneal (i.p.) of immune gamma globulin (IgG) raised against 3'-aminomethylnicotine-recombinant Pseudomonas aeruginosa exoprotein A (NicVAX, Nabi Biopharmaceuticals, Rockville, MD) and seven rats received normal IgG. Rats were observed under blind conditions for somatically expressed nicotine abstinence signs immediately prior to drug termination and at 12, 24, and 36 hr afterward. In Experiment 2, similarly treated rats were observed at 6- and 72-hr postwithdrawal, to test the possibility that immunization altered the time course rather than the intensity of withdrawal syndrome. Experiment 3 tested whether immunized rats were still nicotine dependent. Without pump removal, each rat was challenged by 1/mg/kg mecamylamine HCl and observed for precipitated withdrawal syndrome. RESULTS: In Experiment 1, there was no premature withdrawal syndrome during nicotine infusion. After termination, the immunized group had significantly fewer withdrawal signs than controls. Experiment 2 showed that immunization did not simply alter the timing of the nicotine abstinence syndrome since immunization did not increase signs before or after the usual withdrawal timeframe. In Experiment 3, rats immunized on the final day of infusion were still nicotine dependent since they exhibited a vigorous mecamylamine-precipitated withdrawal syndrome. DISCUSSION: Nicotine antibodies did not precipitate a withdrawal syndrome, and they markedly reduced the severity of spontaneous nicotine withdrawal. The present data suggests that this may be most readily explained by their reported delay of nicotine clearance.
Authors:
David H Malin; William D Moon; Pilar Goyarzu; Nancy Magallanes; Michelle B Blair; Melodee R Alexander; Lauren McDavid; Jason L Spurgeon; Sofiane Ennifar; Ali Fattom
Related Documents :
21818437 - Analysis of the korean emergency department syndromic surveillance system: mass type ac...
95297 - Sick sinus syndrome and av node re-entry.
16052147 - Ethmoidal involvement in "imploding" (silent) sinus syndrome.
917347 - Neuropsychiatric disorders of alcoholism.
6590717 - Popliteal pterygium syndrome presenting with orofacial abnormalities. report of a family.
9390707 - A case of noonan syndrome with cortical dysplasia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-04
Journal Detail:
Title:  Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco     Volume:  12     ISSN:  1469-994X     ISO Abbreviation:  Nicotine Tob. Res.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-06-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815751     Medline TA:  Nicotine Tob Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  438-44     Citation Subset:  IM    
Affiliation:
University of Houston-Clear Lake, 2700 Bay Area Blvd., Houston, TX 77058, USA. malin@uhcl.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Immunization, Passive / methods*
Male
Nicotine / immunology*
Rats
Rats, Sprague-Dawley
Substance Withdrawal Syndrome / drug therapy*,  immunology
Tobacco Use Disorder / immunology*,  prevention & control*
Chemical
Reg. No./Substance:
54-11-5/Nicotine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer...
Next Document:  Differences between intermittent and light daily smokers in a population of U.S. military recruits.